content_copy Science - Vitro Biopharma

Novel Science

Vitro Biopharma is presently focused on adult stem cells known as mesenchymal stem cells or MSCs. The discovery of embryonic stem cells have shown to be capable of differentiating into any cell type in the body and was largely responsible for the development of modern stem cell technology. Embryonic stem cells are also ethically contentious since, in certain cases, embryo destruction results from the use of embryonic stem cells. However, adult stem cells are derived through non-destructive procedures from a variety of tissue sources. Adult stem cells have been approved for clinical use for over 50 years and have a strong record of safety and efficacy for use in the treatment of numerous blood disorders. Presently, the MSC sector of stem cell research is one of the most rapidly growing and expanding fields within the entire stem cell industry.

Comparative Analysis

There are multiple characteristics of umbilical cord MSCs significantly superior to those derived from adipose, bone marrow or placental tissues.

Learn More

Rapid Emergence of Stem Cell Products

The rapid emergence of stem cell products & technology based on MSCs is related to several factors including the widespread availability of these cells from numerous tissue sources and the strong clinical results showing preliminary efficacy and safety in a broad range of indications within disease treatment, recovery from injury and accelerated healing as well as numerous applications in regenerative medicine.

Stem Cell Therapy Decreases Covid Deaths
Stem Cell Therapy Decreases Covid Deaths

0 Comments

Several clinical studies report increased patient survival following the intravenous infusion of mesenchymal stem cells (MSCs) during the past year.  MSCs block the cytokine storm in the lungs and also regenerate cells and tissues damaged by the COVID-19 virus.  MSCs are not vaccines and work differently in the treatment of COVID-19. 

Read More

Stem Cell Activation by Natural Products
Stem Cell Activation by Natural Products

0 Comments

Bone marrow stem cell therapies, based on transplant of hematopoietic stem cells (HSCs) have been used for over 50 years in the treatment of blood disorders including leukemia, lymphoma, and auto-immune disorders. Embryonic stem cells (ESCs) were discovered in the late 1990’s by Evans, Kauffman, and Martin. J Thompson developed procedures to isolate and expand ESCs from human embryos. Since ESCs could differentiate into any cell in the body, this expanded application of stem therapy to include broad areas in disease treatment and regenerative medicine.

Read More

Vascular Fraction and Placental Cell Extract
Comparison of Adipose Stromal Vascular Fraction and Placental Cell Extract

0 Comments

Multipotent mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including osteoarthritis and other conditions,

Read More

Comparative Analysis of Adult Mesenchymal Stem Cells Derived from Adipose, Bone-Marrow, Placenta, and Umbilical Cord Tissue
Comparative Analysis of Adult Mesenchymal Stem Cells

0 Comments

Mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including treatment for osteoarthritis and other conditions. 

Read More